Total Voting Rights

Summary by AI ^BETAClose X

GenIP Plc announces that its total issued share capital now consists of 25,517,461 ordinary shares of £0.00425 each, with no shares held in treasury, meaning the total voting rights available to shareholders for notification purposes under the FCA's Disclosure Guidance and Transparency Rules is 25,517,461.

Disclaimer*

GenIP PLC

29 May 2026

GenIP Plc

("GenIP" or the "Company")

Total Voting Rights

In conformity with the Disclosure Guidance and Transparency Rules ("DTRs") of the Financial Conduct Authority (the "FCA"), GenIP Plc (AIM:GNIP), a technology consultancy providing AI-driven services to help research organisations and corporations commercialise their innovations, announces that as at the date of this announcement the Company's total issued share capital consists of 25,517,461 ordinary shares of £0.00425 with voting rights ("Ordinary Shares"). The Company does not hold any Ordinary Shares in treasury and accordingly there are no voting rights in respect of any treasury shares.

The abovementioned figure of 25,517,461 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, GenIP under the FCA's DTRs.

ENDS

For further information regarding GenIP, please visit www.genip.ai, or contact:

GenIP Plc Melissa Cruz, CEO		Via Redchurch Communications

Beaumont Cornish Limited (Nominated Adviser) Roland Cornish / Asia Szusciak		Tel: +44 (0) 20 7628 3396
AlbR Capital Limited (Broker) Colin Rowbury Jon Belliss		Tel: +44 (0) 20 7399 9427 cr@albrcapital.com Jb@albrcapital.com
CMC Markets (Joint Broker) Douglas Crippen		Tel: +44 (0) 20 3003 8632
Redchurch Communications (Financial PR) John Casey		genip@weareredchurch.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END